Table 1:
Demographic and clinical characteristics of patients on admission
| Variables | Survivor | Non-survivor | Total | P value |
| (n=101) | (n=24) | (n=125) | ||
| Age, years (Mean ± SD) | 46.16 ± 16.99 | 65.83 ± 9.21 | 49.94 ± 17.59 | <0.001 |
| Sex | ||||
| Female | 25 (24.8%) | 7 (29.2%) | 32 (25.6%) | 0.656 |
| Male | 76 (75.2%) | 17 (70.8%) | 93 (74.4%) | |
| Smokers | 13 (12.9%) | 12 (50.0%) | 25 (20.0%) | <0.001 |
| Positive Travel History | 19 (18.8%) | 0 (0.0%) | 19 (15.2%) | 0.021 |
| Known contact history | 52 (51.5%) | 8 (33.3%) | 60 (48.0%) | 0.11 |
| Comorbidities | ||||
| Hypertension | 13 (12.9%) | 12 (50.0%) | 25 (20.0%) | <0.001 |
| Diabetes | 8 (7.9%) | 8 (33.3%) | 16 (12.8%) | 0.001 |
| Ischemic Heart disease | 5 (5.0%) | 9 (37.5%) | 14 (11.2%) | <0.001 |
| Chronic lung disease | 5 (5.0%) | 2 (8.3%) | 7 (5.6%) | 0.517 |
| Malignancy | 2 (2.0%) | 0 (0.0%) | 2 (1.6%) | 0.652 |
| Chronic kidney disease | 1 (1.0%) | 2 (8.3%) | 3 (2.4%) | 0.094 |
| BCG Vaccination done | 69 (68.3%) | 14 (58.3%) | 83 (66.4%) | 0.352 |
| Presenting Symptoms | ||||
| Fever | 42 (41.6%) | 24 (100.0%) | 66 (52.8%) | <0.001 |
| Sore throat | 41 (40.6%) | 23 (95.8%) | 64 (51.2%) | <0.001 |
| Fatigue | 41 (40.6%) | 19 (79.2%) | 60 (48.0%) | 0.001 |
| Cough | 41 (40.6%) | 24 (100.0%) | 65 (52.0%) | <0.001 |
| Myalgia | 0 (0.0%) | 1 (4.2%) | 1 (0.8%) | 0.192 |
| Dyspnoea | 15 (14.9%) | 24 (100.0%) | 39 (31.2%) | <0.001 |
| Headache | 0 (0.0%) | 2 (8.3%) | 2 (1.6%) | 0.036 |
| Diarrhoea | 0 (0.0%) | 1 (4.2%) | 1 (0.8%) | 0.192 |
| Abdominal pain | 0 (0.0%) | 1 (4.2%) | 1 (0.8%) | 0.192 |
| Temperature >37.5.C | 15 (14.9%) | 19 (79.2%) | 34 (27.2%) | <0.001 |
| SpO2 <90% | 12 (11.9%) | 23 (95.8%) | 35 (28.0%) | <0.001 |
| Pulse rate ≥100 beats per min | 10 (9.9%) | 23 (95.8%) | 33 (26.4%) | <0.001 |
| Respiratory Rate ≥30 breaths per min | 14 (13.9%) | 23 (95.8%) | 37 (29.6%) | <0.001 |
| Blood pressure | ||||
| Normotensive | 93 (92.1%) | 13 (54.2%) | 106 (84.8%) | <0.001 |
| Hypotensive | 1 (1.0%) | 9 (37.5%) | 10 (8.0%) | |
| Hypertensive | 7 (6.9%) | 2 (8.3%) | 9 (7.2%) | |
| Respiratory distress | 14 (13.9%) | 24 (100.0%) | 38 (30.4%) | <0.001 |
| Altered sensorium | 0 (0.0%) | 3 (12.5%) | 3 (2.4%) | 0.006 |
| SOFA Score, (Mean ± SD) | 0.50 ± 1.44 | 7.42 ± 3.36 | 1.83 ± 3.35 | <0.001 |
| q-SOFA Score (Mean ± SD) | 0.20 ± 0.40 | 1.67 ± 0.56 | 0.48 ± 0.72 | <0.001 |
| Disease Severity Status | <0.001 | |||
| Asymptomatic | 59 (58.4%) | 0 (0.0%) | 59 (47.2%) | |
| Mild | 27 (26.7%) | 0 (0.0%) | 27 (21.6%) | |
| Moderate | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
| Severe | 14 (13.9%) | 5 (20.8%) | 19 (15.2%) | |
| Critical | 1 (1.0%) | 19 (79.2%) | 20 (16.0%) |